Professional/Scholarly Presentations
Presentations
Pozza R, Biando K, Maisey A, Hassanein T. "Interferon Response Rates in HCV Infected Dialysis Patients Awaiting Renal Transplantation," Viral Hepatitis Conference, Boston, MA, 2004.
Pozza R, Albanese L, Biando K, Hassanein T. "Severity of Liver Disease in ESRD Patients Awaiting Renal Transplantation," DDW, Poster, Orlando, FL, 2003
Pozza R, Albanese L, Biando K, Hassanein T. "Severity of Liver Disease in HCV Antibody Positive ESRD Patients Awaiting Renal Transplantation," Sigma Theta Tau International Annual Research Conference, Poster, Irvine CA, 2002
Pozza R, Albanese L, Biando K, Hassanein T. "Disease Severity in Hepatitis C Positive Dialysis Patients Awaiting Renal Transplantation," International Transplantation Nurses Society Annual Conference, Cambridge England, 2001
Publications
Pozza R, Biando K, Maisey A, Hassanein T. "Interferon Response Rates in HCV Infected Dialysis Patients Awaiting Renal Transplantation." Abstract. Antiviral Therapies, (2004).
Pozza R, Chen P, Monson P, Behling C, Chatfield E, Krinsky M, Hassanein T. "Combination Therapy With or Without Induction for Non-Responders to Interferon Monotherapy." Abstact. Gastroenterology 18, A6492, 2000.
Pozza R, Albanese L, Medley K, Peeters R, Wahlstrom E, Hassanein T. "Prevalence of Hepatitis C in Community Based Screening Programs in Southern California." Abstact. Hepatology 32, A1566, 2000.
Research
Pozza, R. Sub-investigator. "A Phase 3, Randomized, Open-Label Study of the Safety and Efficacy of Two Dose Levels of Interferon Alfacon-1 Plus Ribavirin Administered Daily for 48 Weeks Versus No-Treatment in Hepatitis C Infection Patients Who are Nonresponders to Previous Pegylated Interferon plus Ribavirin therapy." Intermune, 2005
Pozza, R. Sub-investigator. "Randomized Double Blind Multi-Center Study to Compare the Safety and Efficacy of Viramidine to Ribavirin in Treatment Nave Patients with Chronic Hepatitis C." Ribapharm, 2004
Pozza, R. Sub-investigator. "A multi-center, Randomized, Open-Label, Phase IIIb Study Investigating the Safety and Efficacy of Pegylated Interferon alfa-2a Plus Ribavirin for the Treatment of Chronic Hepatitis C Infection in HIV Infected Persons Who Have Failed to Achieve a Sustained Virologic Response Following Previous Interferon Therapy." Roche Pharmaceuticals, 2002
Pozza, R. Sub-investigator. "A randomized Clinical Trial Comparing Two Management Strategies for Treatment of Neutropenia and Anemia Associated With Pegylated Interferon Plus Ribavirin Treatment of Compensated Chronic Hepatitis C in Adult Subjects Infected With HIV." Schering Pharmaceuticals, 2002
Pozza, R. Sub-investigator. "PEG Intron + Ribavirin For the Treatment of Patients with Chronic Hepatitis C." Schering Pharmaceuticals, 2001
View All Professional/Scholarly Presentations
Pozza R, Biando K, Maisey A, Hassanein T. "Interferon Response Rates in HCV Infected Dialysis Patients Awaiting Renal Transplantation," Viral Hepatitis Conference, Boston, MA, 2004.
Pozza R, Albanese L, Biando K, Hassanein T. "Severity of Liver Disease in ESRD Patients Awaiting Renal Transplantation," DDW, Poster, Orlando, FL, 2003
Pozza R, Albanese L, Biando K, Hassanein T. "Severity of Liver Disease in HCV Antibody Positive ESRD Patients Awaiting Renal Transplantation," Sigma Theta Tau International Annual Research Conference, Poster, Irvine CA, 2002
Pozza R, Albanese L, Biando K, Hassanein T. "Disease Severity in Hepatitis C Positive Dialysis Patients Awaiting Renal Transplantation," International Transplantation Nurses Society Annual Conference, Cambridge England, 2001
Publications
Pozza R, Biando K, Maisey A, Hassanein T. "Interferon Response Rates in HCV Infected Dialysis Patients Awaiting Renal Transplantation." Abstract. Antiviral Therapies, (2004).
Pozza R, Chen P, Monson P, Behling C, Chatfield E, Krinsky M, Hassanein T. "Combination Therapy With or Without Induction for Non-Responders to Interferon Monotherapy." Abstact. Gastroenterology 18, A6492, 2000.
Pozza R, Albanese L, Medley K, Peeters R, Wahlstrom E, Hassanein T. "Prevalence of Hepatitis C in Community Based Screening Programs in Southern California." Abstact. Hepatology 32, A1566, 2000.
Research
Pozza, R. Sub-investigator. "A Phase 3, Randomized, Open-Label Study of the Safety and Efficacy of Two Dose Levels of Interferon Alfacon-1 Plus Ribavirin Administered Daily for 48 Weeks Versus No-Treatment in Hepatitis C Infection Patients Who are Nonresponders to Previous Pegylated Interferon plus Ribavirin therapy." Intermune, 2005
Pozza, R. Sub-investigator. "Randomized Double Blind Multi-Center Study to Compare the Safety and Efficacy of Viramidine to Ribavirin in Treatment Nave Patients with Chronic Hepatitis C." Ribapharm, 2004
Pozza, R. Sub-investigator. "A multi-center, Randomized, Open-Label, Phase IIIb Study Investigating the Safety and Efficacy of Pegylated Interferon alfa-2a Plus Ribavirin for the Treatment of Chronic Hepatitis C Infection in HIV Infected Persons Who Have Failed to Achieve a Sustained Virologic Response Following Previous Interferon Therapy." Roche Pharmaceuticals, 2002
Pozza, R. Sub-investigator. "A randomized Clinical Trial Comparing Two Management Strategies for Treatment of Neutropenia and Anemia Associated With Pegylated Interferon Plus Ribavirin Treatment of Compensated Chronic Hepatitis C in Adult Subjects Infected With HIV." Schering Pharmaceuticals, 2002
Pozza, R. Sub-investigator. "PEG Intron + Ribavirin For the Treatment of Patients with Chronic Hepatitis C." Schering Pharmaceuticals, 2001
View All Professional/Scholarly Presentations
Professional Experience
Academic Experience
Associate Professor, School of Nursing, Azusa Pacific University, Azusa, CA, 2000-present
Associate Director of University Honor%u2019s Program Azusa Pacific University, Azusa, CA, 2000-present
Associate Director of Honors, APU, 2003-2005
Associate Dean, School of Nursing, Curriculum and Clinical Practice, 2005-present
Adjunct Faculty, Undergraduate-Adult Medical/Surgical Nursing, Pharmacology, Azusa Pacific University, Azusa CA, 1996-2000
Clinical Work
Hepatology Nurse Practitioner, Southern California Liver Centers, Riverside, CA, 1999-present
Kidney/Pancreas and Liver Transplant Coordinator, Riverside Community Hospital, Riverside, CA, 1996-1999
Outpatient Transplant Clinic Coordinator, Loma Linda University Medical Center, Loma Linda, CA, 1993-1996
Charge Nurse/Staff Nurse, Telemetry and Transplant Units, Loma Linda University Medical Center, Loma Linda, CA, 1990-1993
Staff Nurse, Labor & Delivery, Redlands Community Hospital, Redlands CA, 1990
View All Professional Experience
Associate Professor, School of Nursing, Azusa Pacific University, Azusa, CA, 2000-present
Associate Director of University Honor%u2019s Program Azusa Pacific University, Azusa, CA, 2000-present
Associate Director of Honors, APU, 2003-2005
Associate Dean, School of Nursing, Curriculum and Clinical Practice, 2005-present
Adjunct Faculty, Undergraduate-Adult Medical/Surgical Nursing, Pharmacology, Azusa Pacific University, Azusa CA, 1996-2000
Clinical Work
Hepatology Nurse Practitioner, Southern California Liver Centers, Riverside, CA, 1999-present
Kidney/Pancreas and Liver Transplant Coordinator, Riverside Community Hospital, Riverside, CA, 1996-1999
Outpatient Transplant Clinic Coordinator, Loma Linda University Medical Center, Loma Linda, CA, 1993-1996
Charge Nurse/Staff Nurse, Telemetry and Transplant Units, Loma Linda University Medical Center, Loma Linda, CA, 1990-1993
Staff Nurse, Labor & Delivery, Redlands Community Hospital, Redlands CA, 1990
View All Professional Experience
Professional Involvement and Accomplishments
Honors, Awards, Recognition
Faculty Development Award for Service to the Community, 2004; Alumni Centennial Award, 1999; Nursing Alumni Association Award and Scholarship, 1989; Academic Excellence Award, 1989; Helene Fuld Fellow Award, International Oncology Conference in London, 1988
Associations, Boards, Committees
Associate Member, American Association for the Study of Liver Diseases; Executive Board Member, International Liver Society; Board Member, California Network of Clinical Nurse Specialists, Chair, Eligibility Committee/ Board Member, Sigma Theta Tau International Honor Society, Iota Sigma Chapter, California Coalition of Nurse Practitioners, American Association of Nurse Practitioners; National Association of Clinical Nurse Specialists; American Nephrology Nurses Association; International Transplant Nurses Society
Faculty Development Award for Service to the Community, 2004; Alumni Centennial Award, 1999; Nursing Alumni Association Award and Scholarship, 1989; Academic Excellence Award, 1989; Helene Fuld Fellow Award, International Oncology Conference in London, 1988
Associations, Boards, Committees
Associate Member, American Association for the Study of Liver Diseases; Executive Board Member, International Liver Society; Board Member, California Network of Clinical Nurse Specialists, Chair, Eligibility Committee/ Board Member, Sigma Theta Tau International Honor Society, Iota Sigma Chapter, California Coalition of Nurse Practitioners, American Association of Nurse Practitioners; National Association of Clinical Nurse Specialists; American Nephrology Nurses Association; International Transplant Nurses Society
